Generation Bio (NASDAQ:GBIO) reported quarterly losses of $(0.82) per share which beat the analyst consensus estimate of $(3.17) by 74.17 percent. This is a 64.19 percent increase over losses of $(2.29) per share from the same period last year. The company reported quarterly sales of $1.594 million which beat the analyst consensus estimate of $660.000 thousand by 141.52 percent. This is a 78.90 percent decrease over sales of $7.554 million the same period last year.